RTx-015

· Ray Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RTx-015, covering 2026-02-20 to 2026-02-20. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Safety of RTx-015 Injection in Retinitis Pigmentosa or Choroideremia Patients (ENVISION) [Phase 1]

See pricing